VVX001

· Viravaxx AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VVX001, covering 2021-04-06 to 2021-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 [Phase 2]